Normal function · from ai-gene-review (Q99643, commit 79fe13b38970) · AI-generated, not KB evidence

SDHC encodes the large cytochrome b560 transmembrane subunit of succinate dehydrogenase (SDH, Complex II), a heterotetrameric enzyme (SDHA/SDHB/SDHC/SDHD) embedded in the mitochondrial inner membrane. Together with SDHD, SDHC forms the membrane anchor domain of Complex II, contributing to the ubiquinone (CoQ) binding site and harboring the heme b (cytochrome b560) prosthetic group shared between the two membrane subunits. SDHC has three transmembrane helices and provides key residues (Ile56, Trp61, Met65, Ile69) that directly contact ubiquinone at the Q-site. The heme b is axially coordinated by His127 of SDHC and the corresponding histidine of SDHD. SDHC has no independent catalytic activity; its role is structural (membrane anchoring, heme environment, Q-site formation). Complex II uniquely links the TCA cycle and the electron transport chain by catalyzing succinate oxidation to fumarate (at SDHA) and transferring electrons to ubiquinone at the SDHC/SDHD membrane interface, but does NOT pump protons. SDHC functions as a tumor suppressor; germline loss-of-function mutations and promoter hypermethylation cause paraganglioma/ pheochromocytoma (PPGL3), gastrointestinal stromal tumors (GIST), and Carney triad, via succinate accumulation and pseudohypoxic signaling.

SDHC is the large cytochrome b560 transmembrane subunit of succinate dehydrogenase (Complex II). Together with SDHD, it forms the membrane anchor domain that anchors the catalytic SDHA:SDHB subcomplex in the inner mitochondrial membrane. SDHC provides the His127 axial ligand to the heme b (cytochrome b560) iron atom shared between SDHC and SDHD, making heme binding (GO:0020037) its primary subunit-specific molecular function. SDHC also contributes to ubiquinone binding at the Q-site (residues Ile56, Trp61, Met65, Ile69 directly contact ubiquinone) and to the overall succinate dehydrogenase (quinone) activity (GO:0008177) of the Complex II heterotetramer. The heme b is proposed to serve as an electron sink during the two-electron reduction of ubiquinone. Through Complex II, SDHC participates in mitochondrial electron transport from succinate to ubiquinone (GO:0006121) and the tricarboxylic acid cycle (GO:0006099).
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Hereditary Pheochromocytoma-Paraganglioma Syndrome causative
Carney-Stratakis syndrome untyped
Germline Loss-of-Function Variants
mechanism: Germline SDH complex loss of function
Pheochromocytoma and Paraganglioma untyped
Germline Loss-of-Function Mutations
mechanism: Succinate Dehydrogenase Complex Dysfunction
subtype: PGL3
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
hereditary pheochromocytoma-paraganglioma MONDO:0017366 AD Definitive
2021-06-17
mitochondrial disease MONDO:0044970 UD No Known Disease Relationship
2022-03-07
no dismech entry
Mechanism modules · computed from kb/

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.